Search

everythinglearnresearchcommunity

for

Search:↓

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Hormonal therapies, especially antiandrogens, can help manage Hidradenitis Suppurativa.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Balding men had lower bone density, while balding women had higher hip bone density.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Monitoring for adverse effects in clinical treatments is crucial.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Ancient hair can preserve hormones, revealing health and fertility insights.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.